GOLDMAN SACHS GROUP INC - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2015. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q3 2016$34,000
-40.4%
11,007
-1.7%
0.00%
Q2 2016$57,000
-51.3%
11,194
-11.5%
0.00%
Q1 2015$117,00012,6420.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Alistair Capital Management, L.L.C. 917,400$5,715,0002.56%
Fortress Investment Group LLC 2,481,596$15,460,0000.24%
PERKINS CAPITAL MANAGEMENT INC 14,000$87,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,332,260$8,386,0000.02%
TFS CAPITAL LLC 26,116$163,0000.01%
GROUP ONE TRADING, L.P. 54,815$342,0000.01%
Renaissance Technologies 218,913$1,364,0000.00%
Alberta Investment Management Corp 19,140$128,0000.00%
OAK RIDGE INVESTMENTS LLC 11,055$69,0000.00%
SUMMIT SECURITIES GROUP LLC 600$4,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders